Starpharma (SPL) is in a trading halt pending the release of an...

  1. hewy
    48 Posts.
    clock Created with Sketch.
    28/11/12
    10:15
    Post #: 11117537
    Starpharma (SPL) is in a trading halt pending the release of an announcement regarding the results of the Company’s two phase 3 studies of VivaGel® for the treatment of bacterial vaginosis.
    Likes Created with Sketch.  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.

Top Stories

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.